Motta G, Esposito E, Motta S, Testa D
Istituto di Patologia e Clinica Otorinolaringoiatrica, Università di Napoli Federico II.
Acta Otorhinolaryngol Ital. 2001 Feb;21(1):32-43.
Classification of laryngeal dysplasia, the most appropriate treatments and criteria for evaluation of the results is still a highly controversial issue. The objectives of the present study on the treatment of laryngeal dysplasia lesions are to: 1) evaluate the relative incidence of the various forms of dysplasia in relation to grading of the histopathological findings; 2) establish the prognosis for the various forms of dysplasia considered; 3) determine the results achieved by the author's treatment protocol according to the characteristics of the dysplasia; 4) critically evaluate the classifications of laryngeal dysplasia found in the literature in view of the results of the present study. The study involved 141 patients with vocal cord dysplasia (134 men, 7 women; mean age: 56.2 years) who had come under observation at the E.N.T. Dept. of the University of Naples "Federico II" between January 1981 and April 1998. In all cases the dysplasia was removed by CO2 laser microlaryngoscopy. Of the 141 patients 89 (63.2%) showed mild dysplasia, 14 (9.9%) moderate dysplasia, 20 (14.2%) severe dysplasia and 18 (12.7%) in situ carcinoma. The five-year survival rate showed an overall actuarial survival of 89.1% for all patients while the corrected actuarial survival was 98.5% and local disease control was 86.1%. In 17 cases (12%) the dysplasia lesion recurred, in 11 (7.8%) an infiltrating carcinoma arose. Recurrences in the dysplasia were encountered in 9% of the patients with mild lesions, 7.1% of those with moderate dysplasia, 15% of the subjects with the severe form and in 27.7% of those with in situ carcinoma. An infiltrating carcinoma arose in 5.6% of the cases of mild lesion, in 7.1% of the medium dysplasias, 5% of the severe forms and in 22.2% of those with in situ carcinoma. The recurrences and infiltrating carcinomas were successfully treated with endoscopic CO2 laser surgery. Only three cases (2.1%) required radical surgery (total laryngectomy): these were patients who had not quit smoking and who had not adhered to the planned follow-up. One of the latter patients died with widespread metastases of the laryngeal cancer. The significantly higher incidence of dysplasia recurrences (P = 0.028) and infiltrating carcinomas (P = 0.015) in those patients with in situ carcinoma shows that, when preparing classification and determining prognosis, these pathologies should be considered separately. Moreover, they require a particularly precise follow-up. In conclusion, the following observations can be drawn from the study: mild and moderate dysplasias are more frequent as compared to severe dysplasia and carcinoma in situ; carcinoma in situ should be distinguished for classification and prognosis from dysplasias, considering their different clinical course and evolution; CO2 laser surgery in these forms is a valid therapeutic approach for its precision, the achievable results, the reduced discomfort to patients and for its evident cost-effectiveness.
喉发育异常的分类、最合适的治疗方法以及评估结果的标准仍然是一个极具争议的问题。本研究针对喉发育异常病变的治疗目标如下:1)评估各种发育异常形式相对于组织病理学检查结果分级的相对发生率;2)确定所考虑的各种发育异常形式的预后;3)根据发育异常的特征确定作者治疗方案所取得的结果;4)鉴于本研究的结果,批判性地评估文献中发现的喉发育异常分类。该研究纳入了141例声带发育异常患者(134例男性,7例女性;平均年龄:56.2岁),这些患者于1981年1月至1998年4月期间在那不勒斯“费德里科二世”大学耳鼻喉科接受观察。所有病例均通过二氧化碳激光显微喉镜切除发育异常组织。141例患者中,89例(63.2%)表现为轻度发育异常,14例(9.9%)为中度发育异常,20例(14.2%)为重度发育异常,18例(12.7%)为原位癌。五年生存率显示,所有患者的总体精算生存率为89.1%,校正精算生存率为98.5%,局部疾病控制率为86.1%。17例(12%)发育异常病变复发,11例(7.8%)出现浸润性癌。轻度病变患者中9%出现发育异常复发,中度发育异常患者中7.1%出现复发,重度发育异常患者中15%出现复发,原位癌患者中27.7%出现复发。轻度病变病例中5.6%出现浸润性癌,中度发育异常病例中7.1%出现浸润性癌,重度发育异常病例中5%出现浸润性癌,原位癌患者中22.2%出现浸润性癌。复发和浸润性癌通过内镜二氧化碳激光手术成功治疗。仅3例(2.1%)需要进行根治性手术(全喉切除术):这些患者未戒烟且未坚持计划的随访。后一位患者死于喉癌广泛转移。原位癌患者中发育异常复发(P = 0.028)和浸润性癌(P = 0.015)的发生率显著更高,这表明在进行分类和确定预后时,应将这些病理情况分开考虑。此外,它们需要特别精确的随访。总之,从该研究中可以得出以下观察结果:与重度发育异常和原位癌相比,轻度和中度发育异常更为常见;考虑到原位癌和发育异常不同的临床病程及演变,在分类和预后方面应将原位癌与发育异常区分开来;二氧化碳激光手术对于这些病变形式而言是一种有效的治疗方法,因其精确性、可取得的结果、对患者不适的减轻以及明显的成本效益。